King-Devick technologies, inc. (KDT) offers a broad set of evidence-based tools utilizing integrated technology for concussion pitchside screening, reading performance, and as indicators of neurological function.
King-Devick products have been scientifically validated in more than 200 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, migraine headaches, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation, ALS and age-related macular degeneration (AMD).
King-Devick Test in association
with Mayo Clinic
In an effort to increase concussion screening awareness, in 2015, Mayo Clinic and King-Devick technologies, inc. announced that they had executed a licensing agreement to co-brand the King-Devick sideline test to King-Devick Test in association with Mayo Clinic. Read the complete press release here.